Biotech

All Articles

Sanofi flunks MS research study, inflicting another blow to Denali treaty

.Sanofi has quit a stage 2 ordeal of Denali Therapeutics-partnered oditrasertib in multiple sclerosi...

Turnstone gives up 60%, shocks C-suite to stretch out cash money

.Turnstone Biologics is lessening its head count by 60% as well as shocking its own C-suite in order...

Gilead surrenders on $15M MASH wager after reviewing preclinical data

.In a year that has found a permission as well as a boating of readouts for metabolic dysfunction-as...

Texas biotech centers cancer deal, pins hopes on being overweight

.Alaunos Therapeutics is axing a contract along with Precigen, surrendering licensing legal rights t...

Capricor allotments even more data for DMD treatment after initiating BLA

.Capricor Rehabs is actually taking a victory tour for their phase 2 Duchenne muscle dystrophy (DMD)...

FDA locations Kezar lupus test in grip complying with 4 patient fatalities

.The FDA has positioned Kezar Life Sciences' lupus test on grip after the biotech hailed four deaths...

Phase 3 Intellectual Rock test attacks SMA target, delivering stockpile 200%

.A stage 3 trial of Scholar Rock's back muscle atrophy (SMA) applicant has actually reached its main...

CAMP 4 is most current to eye IPO, while Upstream spells out $182M strategy

.RNA biotech CAMP4 Therapies has marked out plans for a $67 thousand IPO, along with inflammation-fo...

Galecto acquires leukemia medicine, goes down bone cancer property in pivot

.A year after the failing of an idiopathic lung fibrosis prospect sent Galecto on a search for redem...

Judo throws down $100M to knock senseless kidney disease

.Taking the mat is actually Judo Biography, a promising biotech equipped along with $one hundred tho...